Lantern Pharma says no exposure to SVB, Signature Bank or Silvergate Capital

Lantern Pharma (LTRN) announced that neither Lantern Pharma Inc. nor any of its subsidiaries had any exposure to Silicon Valley Bank (SIVB), Silvergate Bank (SI), or Signature Bank (SBNY). Lantern’s cash, cash equivalents, and marketable securities are managed across top-tier financial institutions and with a multiple-tiered account approach. Lantern’s cash, cash equivalents, and marketable securities are sufficient to continue development and current operations into 2025.